Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and maintenance strategies of two-compound formulation calcipotriol and betamethasone dipropionate gel (Xamiol® gel) in the treatment of scalp psoriasis: results from a study in 885 patients.
Saraceno R, Camplone G, D'Agostino M, De Simone C, Di Cesare A, Filosa G, Frascione P, Gabellini M, Lunghi F, Mazzotta A, Peris K, Scotto Di Luzio G, Calvieri S, Simonacci M, Chimenti S. Saraceno R, et al. Among authors: simonacci m. J Dermatolog Treat. 2014 Feb;25(1):30-3. doi: 10.3109/09546634.2013.800182. Epub 2013 May 23. J Dermatolog Treat. 2014. PMID: 23621170 Free article. Clinical Trial.
Treating psoriasis with etanercept in italian clinical practice: prescribing practices and duration of remission following discontinuation.
Arcese A, Aste N, Bettacchi A, Camplone G, Cantoresi F, Caproni M, D'Amico D, Fabbri P, Filosa G, Galluccio A, Hansel K, Lisi P, Micali G, Musumeci ML, Nicolini M, Parodi A, Patania M, Pezza M, Potenza C, Richetta A, Simonacci M, Trevisan P, Valenti G, Calvieri S. Arcese A, et al. Among authors: simonacci m. Clin Drug Investig. 2010;30(8):507-16. doi: 10.2165/11537470-000000000-00000. Clin Drug Investig. 2010. PMID: 20586516
Switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group.
Ganzetti G, Campanati A, Bettacchi A, Brandozzi G, Brisigotti V, Bugatti L, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A. Ganzetti G, et al. Among authors: simonacci m. G Ital Dermatol Venereol. 2018 Feb;153(1):5-10. doi: 10.23736/S0392-0488.16.05463-8. Epub 2016 Nov 15. G Ital Dermatol Venereol. 2018. PMID: 27845513
The transitioning from conventional therapy to biological treatment in psoriatic patients: STRATOS, a project of Marche Region.
Ganzetti G, Campanati A, Bernardini ML, Bettacchi A, Brandozzi G, Brisigotti V, Cataldi I, Filosa G, Giacchetti A, Lemme G, Morresi L, Nicolini M, Postacchini V, Ricotti G, Rosa L, Simonacci M, Offidani A. Ganzetti G, et al. Among authors: simonacci m. G Ital Dermatol Venereol. 2016 Aug;151(4):340-6. Epub 2015 Jun 19. G Ital Dermatol Venereol. 2016. PMID: 26091276
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints.
Rupoli S, Goteri G, Morsia E, Torre E, Giantomassi F, Campanati A, Offidani AM, Molinelli E, Brandozzi G, Serresi S, Giacchetti A, Bugatti L, Filosa G, Mozzicafreddo G, Simonacci M, Olivieri A. Rupoli S, et al. Among authors: simonacci m. Dermatol Ther. 2022 Oct;35(10):e15737. doi: 10.1111/dth.15737. Epub 2022 Aug 9. Dermatol Ther. 2022. PMID: 35903895
Results of a prospective phase II trial with oral low-dose bexarotene plus photochemotherapy (PUVA) in refractory and/or relapsed patients with mycosis fungoides.
Rupoli S, Canafoglia L, Goteri G, Leoni P, Brandozzi G, Federici I, Micucci G, Giantomassi F, Mozzicafreddo G, Alterini R, Filosa G, Ricotti G, Simonacci M, Scortechini AR, Zizzi A, Pimpinelli N. Rupoli S, et al. Among authors: simonacci m. Eur J Dermatol. 2016 Jan-Feb;26(1):13-20. doi: 10.1684/ejd.2015.2672. Eur J Dermatol. 2016. PMID: 26678311 Clinical Trial.
42 results